<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01530087</url>
  </required_header>
  <id_info>
    <org_study_id>4518-O</org_study_id>
    <secondary_id>CIV-GB-11-07-001241</secondary_id>
    <nct_id>NCT01530087</nct_id>
  </id_info>
  <brief_title>Preliminary Evaluation of CASTLE Barrier Prototype UK</brief_title>
  <official_title>Peristomal Skin Irritation: A Preliminary Evaluation of the CASTLE Barrier Prototype for People With Intestinal Stomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hollister Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hollister Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to provide preliminary assessment of the safety and performance
      of a novel barrier formulation (CASTLE) in a small population of subjects with irritated
      peristomal skin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-site, unblinded, historically controlled, first use in humans study of a
      stoma barrier with a new formulation. Approximately 34 subjects who are currently using a
      2-piece tape bordered product and able and willing to wear a product will be enrolled. Each
      participant is provided with one box containing 20 of the test barriers to be used
      consecutively according to their normal routine. Each participant is also provided with a box
      containing 30 pouches selected to most closely resemble their current product. Participants
      are asked to record the time of application and time of removal of each test barrier and
      their assessment of relevant characteristics for each test barrier. A clinical evaluation of
      the peristomal skin is conducted at study entry, at approximately mid way through the study
      and again at its conclusion. Photographs are taken of the peristomal skin at each visit using
      a digital camera. Individual participation in terms of wearing the barrier is for 30 days or
      until the test barrier has been used up, whichever comes first. The study is comprised of 3
      visits, an enrolment visit, a mid-study visit and a completion visit and a phone call at
      approximately day 7.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Inability of site to recruit/enroll target population
  </why_stopped>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peristomal Skin Condition</measure>
    <time_frame>1 - 30 days</time_frame>
    <description>mean irritation score using a categorical scale with range of 1(normal) to 5(eroded or heaemorrhagic dermatitis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Security</measure>
    <time_frame>30 days</time_frame>
    <description>wear time leakage barrier erosion</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Peristomal Skin Complication</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CASTLE Barrier</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CASTLE barrier</intervention_name>
    <description>Prototype barrier to be used in place of current two piece device</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 18 years of age

          -  has colostomy or ileostomy

          -  current uses two piece tape bordered barrier

          -  has mild to moderate peristomal skin irritation

          -  cares for their stoma independently in the community

          -  at least 3 months post-operative

          -  provides informed consent

        Exclusion Criteria:

          -  has fistula on or near stoma

          -  has been involved in stoma care study in the last 30 days

          -  is pregnant or lactating (determined by interview only)

          -  has existing medical condition that would compromise their participation or follow-up

          -  currently uses convex ostomy products, paste and/or rings

          -  is allergic to test barrier components

          -  is undergoing chemo- or radiotherapy that may affect the interpretation of the results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Murahata, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hollister Incorporated</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>York Teaching Hospital</name>
      <address>
        <city>York</city>
        <zip>YO31 8HE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2012</study_first_submitted>
  <study_first_submitted_qc>February 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2012</study_first_posted>
  <results_first_submitted>September 22, 2015</results_first_submitted>
  <results_first_submitted_qc>February 22, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 22, 2016</results_first_posted>
  <last_update_submitted>February 22, 2016</last_update_submitted>
  <last_update_submitted_qc>February 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>colostomy</keyword>
  <keyword>ileostomy</keyword>
  <keyword>irritant dermatitis</keyword>
  <keyword>two piece barrier</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Subjects With Ileostomy or Colostomy</title>
          <description>CASTLE Barrier ostomy device
CASTLE barrier: Prototype barrier to be used in place of current two piece device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Subjects With Ileostomy or Colostomy</title>
          <description>CASTLE Barrier ostomy device
CASTLE barrier: Prototype barrier to be used in place of current two piece device</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Peristomal Skin Condition</title>
        <description>mean irritation score using a categorical scale with range of 1(normal) to 5(eroded or heaemorrhagic dermatitis)</description>
        <time_frame>1 - 30 days</time_frame>
        <population>Study was stopped due to inability to inability to enroll. No data are available for any outcome measures.</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>CASTLE Barrier: Prototype barrier used in place of previous two piece device</description>
          </group>
        </group_list>
        <measure>
          <title>Peristomal Skin Condition</title>
          <description>mean irritation score using a categorical scale with range of 1(normal) to 5(eroded or heaemorrhagic dermatitis)</description>
          <population>Study was stopped due to inability to inability to enroll. No data are available for any outcome measures.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Security</title>
        <description>wear time leakage barrier erosion</description>
        <time_frame>30 days</time_frame>
        <population>Study was stopped ; no data are available</population>
        <group_list>
          <group group_id="O1">
            <title>Treatment</title>
            <description>CASTLE Barrier
CASTLE barrier: Prototype barrier to be used in place of current two piece device</description>
          </group>
        </group_list>
        <measure>
          <title>Security</title>
          <description>wear time leakage barrier erosion</description>
          <population>Study was stopped ; no data are available</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Subjects With Ileostomy or Colostomy</title>
          <description>CASTLE Barrier ostomy device
CASTLE barrier: Prototype barrier to be used in place of current two piece device</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director, Global Clinical Affairs</name_or_title>
      <organization>Hollister Incorporated</organization>
      <phone>847.918.3467</phone>
      <email>Stacy.Haddad@hollister.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

